Nyakyoma Kazare, Morriss Richard
University of Nottingham, Nottingham, UK.
Psychopharmacol Bull. 2010;43(2):67-81.
Previous naturalistic observational studies have produced mixed results concerning the effectiveness of clozapine on hospitalization, partly because the decision to place a patient on clozapine versus another antipsychotic has been confounded with the known efficacy of clozapine over other antipsychotics.
To examine the effectiveness of clozapine compared to other antipsychotic drugs in delaying hospitalization in routine clinical practice.
Consecutive patients with schizophrenia or schizoaffective disorders registered to start on clozapine in one English mental health service over a six-year period were followed up for 2 years from the time of discharge (index admission). Time to hospitalization was used to compare patients started and discharged on clozapine (CG = 126) and those registered to start on clozapine but subsequently discharged on other antipsychotics (OAG = 34) using Kaplan-Meier survival analysis.
There were more hospitalizations with OAG 13 [38%] than CG = 27 [21%]. Time to hospitalization (25th centile) was 299 days in CG and 136 days in OAG among patients who were successfully discharged from hospital (x2 = 4.80, df = 1, p = 0.043). The time to hospitalization was delayed in CG versus other OAG when baseline differences in age, gender, marital status, previous forensic mental health service, case management and site of initiation were controlled [odds ratio (95% confidence intervals) = 1.87 (1.01, 4.33), p = 0.048].
Clozapine delays hospitalization in patients with treatment resistant schizophrenia if they are started on clozapine in the community or successfully discharged from hospital following their index admission.
先前的自然观察性研究关于氯氮平对住院率的有效性得出了不一致的结果,部分原因是决定让患者使用氯氮平而非其他抗精神病药物,这与氯氮平相对于其他抗精神病药物的已知疗效相互混淆。
在常规临床实践中,研究氯氮平与其他抗精神病药物相比在延迟住院方面的有效性。
在一项英国精神卫生服务机构中,连续6年登记开始使用氯氮平的精神分裂症或分裂情感性障碍患者,从出院(首次入院)时间起随访2年。使用Kaplan-Meier生存分析,比较开始并出院时使用氯氮平的患者(CG = 126)和登记开始使用氯氮平但随后出院时使用其他抗精神病药物的患者(OAG = 34)的住院时间。
OAG组有13例[38%]住院,多于CG组的27例[21%]。成功出院的患者中,CG组住院时间(第25百分位数)为299天,OAG组为136天(χ² = 4.80,自由度 = 1,p = 0.043)。当控制年龄、性别、婚姻状况、先前的法医精神卫生服务、病例管理和起始地点的基线差异时,CG组与其他OAG组相比,住院时间延迟[比值比(95%置信区间)= 1.87(1.01,4.33),p = 0.048]。
对于难治性精神分裂症患者,如果在社区开始使用氯氮平或首次入院后成功出院,氯氮平可延迟住院。